Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV envelope glycoprotein (Env) trimer V2 apex region is a segment at the top of the Env trimer, formed by portions of the variable loops V1 and V2 from each gp120 subunit. It mediates viral attachment and fusion and is a major target for broadly neutralizing antibodies. The region is characterized by dense glycosylation, sequence variability, and a hydrophobic core, presenting significant challenges for vaccine development, but also opportunities for immunogen design focused on eliciting bnAbs.
Neutralization of viral entry via antibody binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Envelope Glycoprotein Trimer V2 Apex Region (V2 Apex).